Proterro

Proterro is the only bio-feedstock company that makes sucrose instead of extracting it from crops. Because of this, its non-crop based, noncellulosic, fermentation-ready sugar feedstock avoids the pricing volatility associated with corn and other feedstock markets, ensuring an economical and scalable production of biofuels and biobased chemicals. Proterro, Inc. develops and markets sugar feedstock. The company offers PROTOSE sugar, a fortified sucrose that produces commercial scale fuels and chemicals through industrial fermentation methods. Proterro, Inc. was founded in 2008 and is based in Princeton, New Jersey.

The Green Fund – researches marijuana, and agricultural stocks as well as stocks that will be effected by this growing trend. 

 

PROPRIETARY PROCESS
for high value products from cyanobacteria with direct applicability to the Food, Feed, and Energy Industries.

Proterro is a biotechnology company that converts waste CO2 into valuable products under license agreements with our partners. Our technology utilizes cyanobacteria in a patented, fully integrated production system to produce cost-competitive products for partners in the global food, feed, and energy industries.

ABOUT PROTERRO

Investors & Advisors

Proterro is partnering with market leaders in the Food, Animal Feed, and Energy industries to create products that exceed their expectations, delight their customers, and nourish a growing population in an increasingly resource constrained world.

PRODUCTS
With a bespoke approach to product design, Proterro employs our patented technology platform to develop products for our partners that:

Are tailored to their specific requirements
Offer price stability
Provide reliable supply
Proterro’s system utilizes waste CO2, captured at its source, and converts it into a range of high value products in two primary categories.

Proterro Sugars

  • Industrial grade
  • Food grade and specialty

Proterro Nutritionals

  • Organic acids
  • Amino acids
  • Nutrients and vitamins

Proterro’s partners leverage our existing intellectual property and unique biotech capabilities to accelerate their product innovation. Our partners define molecule structures that meet their end use requirements and establish purity standards for final products.

LEAVE A REPLY

Please enter your comment!
Please enter your name here